About Veenat - 400 mg Tablets
Veenat - 400 mg Tablets are a celebrated choice for adults seeking potent cancer treatment. Manufactured and marketed by Natco Pharma Ltd., this sought-after medicine features Imatinib Mesylate, a decorated tyrosine kinase inhibitor. The film-coated, light yellow, oval tablets deliver instant savings and the lowest price, making them an affordable solution, especially when sourced from reliable suppliers in India. Personalise your therapy with confidence-these odorless, prescription-only tablets are blister-packed for freshness and should be swallowed whole for immediate release and optimal efficacy.
Highlighted Features and Applications of Veenat - 400 mg Tablets
Veenat - 400 mg Tablets are distinguished by their film-coated technology and potent action against various cancers, especially leukemia and gastrointestinal tumors. These tablets are designed exclusively for adult patients and are taken orally for immediate absorption. Their decorated track record highlights their significance in modern oncology, offering patients a reliable option. Use is strictly guided by prescription, ensuring safety and effective personalised treatment for each patient group.
Packaging, Pricing, and Distribution Details for Veenat - 400 mg Tablets
Veenat - 400 mg Tablets are securely packaged in blister packs, ensuring both hygiene and convenience for storage and handling. Available typically in packs of 10 tablets, the product is offered at competitive list prices, reflecting instant savings for buyers seeking the lowest price. Natco Pharma caters to the main domestic market in India, with sample policies available for hospitals and pharmaceutical traders. Efficient transport services further streamline nationwide distribution and reach.
FAQ's of Veenat - 400 mg Tablets:
Q: How should Veenat - 400 mg Tablets be taken for best results?
A: Veenat - 400 mg Tablets should be swallowed whole, not split or crushed, following your healthcare provider's instructions to ensure optimal absorption and efficacy.
Q: What is the primary benefit of using Veenat - 400 mg Tablets?
A: The primary benefit of Veenat - 400 mg Tablets is their potent anticancer effect, attributed to the tyrosine kinase inhibitor Imatinib Mesylate, which is especially effective in treating certain leukemias and gastrointestinal tumors.
Q: When is Veenat - 400 mg prescribed to patients?
A: Veenat - 400 mg is prescribed for adults diagnosed with specific types of cancer upon recommendation by a qualified healthcare professional and requires a valid prescription.
Q: Where does the manufacture and distribution of Veenat - 400 mg Tablets occur?
A: Veenat - 400 mg Tablets are manufactured and marketed by Natco Pharma Ltd. in India, with secure national distribution supported by established transport services.
Q: What is the proper way to store Veenat - 400 mg Tablets?
A: Store Veenat - 400 mg Tablets below 30C in a dry place, within their original blister packaging, and away from moisture or direct sunlight to maintain efficacy.